There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
This study was undertaken to investigate the effects of epidermal growth factor receptor
(EGFR) mutation and its downstream signaling on response and survival in non-small-cell
lung cancer (NSCLC) patients treated with gefitinib.